Abstract

1. Abstract
1.1. Objectives: To explore the clinical characteristics of anticoagulant rodenticide poisoning and the efficacy of vitamin K1 therapy.
1.2. Methods: Eighty-two patients with anticoagulant rodenticide poisoning, treated in the Emergency Internal Medicine Department of our hospital, from January 2013 to December 2018, were selected as subjects. Clinical data, including poisoning details, time from poisoning to treatment, clinical manifestations, coagulation functions, treatment regimens and treatment outcomes were retrospectively collected and analyzed. All patients were followed up for three months.